Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Growth (Status and Outlook) 2022-2028
- LP 4929812
- 104 Pages
- March 2022
- Medical Devices
The United States Paroxysmal Nocturnal Hemoglobinuria Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Paroxysmal Nocturnal Hemoglobinuria Treatment market, reaching US$ million by the year 2028. As for the Europe Paroxysmal Nocturnal Hemoglobinuria Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Paroxysmal Nocturnal Hemoglobinuria Treatment players cover Achillion Pharmaceuticals Inc, Akari Therapeutics Plc, Alexion Pharmaceuticals Inc, and Alnylam Pharmaceuticals Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Paroxysmal Nocturnal Hemoglobinuria Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
ACH-4471
ALN-CC5
ALXN-1210
AMY-101
APL-2
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Achillion Pharmaceuticals Inc
Akari Therapeutics Plc
Alexion Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Amgen Inc
Apellis Pharmaceuticals Inc
F. Hoffmann-La Roche Ltd
ISU ABXIS Co Ltd
Novartis AG
NovelMed Therapeutics Inc
Omeros Corp
Ra Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc
Regenesance BV
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2017-2028
2.1.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Segment by Type
2.2.1 ACH-4471
2.2.2 ALN-CC5
2.2.3 ALXN-1210
2.2.4 AMY-101
2.2.5 APL-2
2.2.6 Others
2.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type
2.3.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type (2017-2022)
2.4 Paroxysmal Nocturnal Hemoglobinuria Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application
2.5.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application (2017-2022)
3 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Player
3.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Players
3.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Players (2020-2022)
3.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Paroxysmal Nocturnal Hemoglobinuria Treatment by Regions
4.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Regions (2017-2022)
4.2 Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth (2017-2022)
4.3 APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth (2017-2022)
4.4 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2017-2022)
5.2 Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022)
5.3 Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (2017-2022)
6.2 APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022)
6.3 APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment by Country (2017-2022)
7.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022)
7.3 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment by Region (2017-2022)
8.2 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast by Regions (2023-2028)
10.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast
10.1.3 APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast
10.1.4 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast
10.1.5 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast
10.2 Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast by Country (2023-2028)
10.2.1 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.2.2 Canada Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.2.3 Mexico Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.2.4 Brazil Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.3 APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast by Region (2023-2028)
10.3.1 China Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.3.2 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.3.3 Korea Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.3.4 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.3.5 India Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.3.6 Australia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.4 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast by Country (2023-2028)
10.4.1 Germany Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.4.2 France Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.4.3 UK Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.4.4 Italy Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.4.5 Russia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.5 Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.5.2 South Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.5.3 Israel Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.5.4 Turkey Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.5.5 GCC Countries Paroxysmal Nocturnal Hemoglobinuria Treatment Market Forecast
10.6 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast by Type (2023-2028)
10.7 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Achillion Pharmaceuticals Inc
11.1.1 Achillion Pharmaceuticals Inc Company Information
11.1.2 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.1.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Achillion Pharmaceuticals Inc Main Business Overview
11.1.5 Achillion Pharmaceuticals Inc Latest Developments
11.2 Akari Therapeutics Plc
11.2.1 Akari Therapeutics Plc Company Information
11.2.2 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.2.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Akari Therapeutics Plc Main Business Overview
11.2.5 Akari Therapeutics Plc Latest Developments
11.3 Alexion Pharmaceuticals Inc
11.3.1 Alexion Pharmaceuticals Inc Company Information
11.3.2 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.3.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Alexion Pharmaceuticals Inc Main Business Overview
11.3.5 Alexion Pharmaceuticals Inc Latest Developments
11.4 Alnylam Pharmaceuticals Inc
11.4.1 Alnylam Pharmaceuticals Inc Company Information
11.4.2 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.4.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Alnylam Pharmaceuticals Inc Main Business Overview
11.4.5 Alnylam Pharmaceuticals Inc Latest Developments
11.5 Amgen Inc
11.5.1 Amgen Inc Company Information
11.5.2 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.5.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Amgen Inc Main Business Overview
11.5.5 Amgen Inc Latest Developments
11.6 Apellis Pharmaceuticals Inc
11.6.1 Apellis Pharmaceuticals Inc Company Information
11.6.2 Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.6.3 Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Apellis Pharmaceuticals Inc Main Business Overview
11.6.5 Apellis Pharmaceuticals Inc Latest Developments
11.7 F. Hoffmann-La Roche Ltd
11.7.1 F. Hoffmann-La Roche Ltd Company Information
11.7.2 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.7.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.7.5 F. Hoffmann-La Roche Ltd Latest Developments
11.8 ISU ABXIS Co Ltd
11.8.1 ISU ABXIS Co Ltd Company Information
11.8.2 ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.8.3 ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 ISU ABXIS Co Ltd Main Business Overview
11.8.5 ISU ABXIS Co Ltd Latest Developments
11.9 Novartis AG
11.9.1 Novartis AG Company Information
11.9.2 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.9.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Novartis AG Main Business Overview
11.9.5 Novartis AG Latest Developments
11.10 NovelMed Therapeutics Inc
11.10.1 NovelMed Therapeutics Inc Company Information
11.10.2 NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.10.3 NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 NovelMed Therapeutics Inc Main Business Overview
11.10.5 NovelMed Therapeutics Inc Latest Developments
11.11 Omeros Corp
11.11.1 Omeros Corp Company Information
11.11.2 Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.11.3 Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Omeros Corp Main Business Overview
11.11.5 Omeros Corp Latest Developments
11.12 Ra Pharmaceuticals Inc
11.12.1 Ra Pharmaceuticals Inc Company Information
11.12.2 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.12.3 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Ra Pharmaceuticals Inc Main Business Overview
11.12.5 Ra Pharmaceuticals Inc Latest Developments
11.13 Regeneron Pharmaceuticals Inc
11.13.1 Regeneron Pharmaceuticals Inc Company Information
11.13.2 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.13.3 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Regeneron Pharmaceuticals Inc Main Business Overview
11.13.5 Regeneron Pharmaceuticals Inc Latest Developments
11.14 Regenesance BV
11.14.1 Regenesance BV Company Information
11.14.2 Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
11.14.3 Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Regenesance BV Main Business Overview
11.14.5 Regenesance BV Latest Developments
12 Research Findings and Conclusion
Table 1. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of ACH-4471
Table 3. Major Players of ALN-CC5
Table 4. Major Players of ALXN-1210
Table 5. Major Players of AMY-101
Table 6. Major Players of APL-2
Table 7. Major Players of Others
Table 8. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type (2017-2022)
Table 11. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application (2017-2022)
Table 14. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Player (2020-2022)
Table 16. Paroxysmal Nocturnal Hemoglobinuria Treatment Key Players Head office and Products Offered
Table 17. Paroxysmal Nocturnal Hemoglobinuria Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Regions (2017-2022)
Table 22. Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Country (2017-2022)
Table 24. Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type (2017-2022)
Table 26. Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application (2017-2022)
Table 28. APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Region (2017-2022)
Table 30. APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type (2017-2022)
Table 32. APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application (2017-2022)
Table 34. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Country (2017-2022)
Table 36. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type (2017-2022)
Table 38. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Paroxysmal Nocturnal Hemoglobinuria Treatment
Table 47. Key Market Challenges & Risks of Paroxysmal Nocturnal Hemoglobinuria Treatment
Table 48. Key Industry Trends of Paroxysmal Nocturnal Hemoglobinuria Treatment
Table 49. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 55. Achillion Pharmaceuticals Inc Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 56. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 57. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. Achillion Pharmaceuticals Inc Main Business
Table 59. Achillion Pharmaceuticals Inc Latest Developments
Table 60. Akari Therapeutics Plc Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 61. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 62. Akari Therapeutics Plc Main Business
Table 63. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Akari Therapeutics Plc Latest Developments
Table 65. Alexion Pharmaceuticals Inc Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 66. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 67. Alexion Pharmaceuticals Inc Main Business
Table 68. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. Alexion Pharmaceuticals Inc Latest Developments
Table 70. Alnylam Pharmaceuticals Inc Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 71. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 72. Alnylam Pharmaceuticals Inc Main Business
Table 73. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 74. Alnylam Pharmaceuticals Inc Latest Developments
Table 75. Amgen Inc Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 76. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 77. Amgen Inc Main Business
Table 78. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 79. Amgen Inc Latest Developments
Table 80. Apellis Pharmaceuticals Inc Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 81. Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 82. Apellis Pharmaceuticals Inc Main Business
Table 83. Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 84. Apellis Pharmaceuticals Inc Latest Developments
Table 85. F. Hoffmann-La Roche Ltd Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 86. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 87. F. Hoffmann-La Roche Ltd Main Business
Table 88. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 89. F. Hoffmann-La Roche Ltd Latest Developments
Table 90. ISU ABXIS Co Ltd Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 91. ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 92. ISU ABXIS Co Ltd Main Business
Table 93. ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 94. ISU ABXIS Co Ltd Latest Developments
Table 95. Novartis AG Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 96. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 97. Novartis AG Main Business
Table 98. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 99. Novartis AG Latest Developments
Table 100. NovelMed Therapeutics Inc Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 101. NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 102. NovelMed Therapeutics Inc Main Business
Table 103. NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. NovelMed Therapeutics Inc Latest Developments
Table 105. Omeros Corp Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 106. Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 107. Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 108. Omeros Corp Main Business
Table 109. Omeros Corp Latest Developments
Table 110. Ra Pharmaceuticals Inc Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 111. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 112. Ra Pharmaceuticals Inc Main Business
Table 113. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 114. Ra Pharmaceuticals Inc Latest Developments
Table 115. Regeneron Pharmaceuticals Inc Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 116. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 117. Regeneron Pharmaceuticals Inc Main Business
Table 118. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 119. Regeneron Pharmaceuticals Inc Latest Developments
Table 120. Regenesance BV Details, Company Type, Paroxysmal Nocturnal Hemoglobinuria Treatment Area Served and Its Competitors
Table 121. Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Product Offered
Table 122. Regenesance BV Main Business
Table 123. Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 124. Regenesance BV Latest Developments
List of Figures
Figure 1. Paroxysmal Nocturnal Hemoglobinuria Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type in 2021
Figure 7. Paroxysmal Nocturnal Hemoglobinuria Treatment in Hospital
Figure 8. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Paroxysmal Nocturnal Hemoglobinuria Treatment in Clinic
Figure 10. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Paroxysmal Nocturnal Hemoglobinuria Treatment in Others
Figure 12. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application in 2021
Figure 14. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Player in 2021
Figure 15. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2017-2022 ($ Millions)
Figure 17. APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2017-2022 ($ Millions)
Figure 18. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Value Market Share by Country in 2021
Figure 21. Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Consumption Market Share by Type in 2021
Figure 22. Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application in 2021
Figure 23. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Region in 2021
Figure 28. APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application in 2021
Figure 29. China Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Country in 2021
Figure 36. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type in 2021
Figure 37. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application in 2021
Figure 38. Germany Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Market Share by Application in 2021
Figure 46. Egypt Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 52. APAC Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 53. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 55. United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Canada Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 59. China Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Korea Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 63. India Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Australia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Germany Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 66. France Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 67. UK Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Italy Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Russia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Spain Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Israel Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
